The formulation design for pioglitazone rapid-release tablet

Chinese Pharmaceutical Journal

Volumn 52, Issue 5, 2000, Pages 295-303

  Chen, G L ^a   Kuo, M K ^a   Chen, Y P ^a   Liu, C H ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

HPLC; Pioglitazone; Rapid release; Type 2 diabetes mellitus; UV

Indexed keywords

CORRELATION METHODS; DISEASE CONTROL; ULTRAVIOLET DEVICES;

CORRELATION COEFFICIENTS;

DRUG PRODUCTS;

PIOGLITAZONE;

ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG FORMULATION; DRUG HALF LIFE; DRUG PURITY; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET;

EID: 0034451318     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: Effects of dietary fructose alone or in combination with pioglitazone
2. "Glitazones", a prospect for non-insulin-dependent diabetes
3. FDA approves pioglitazone for diabetes
4. New drug overview. Pioglitazone hydrochloride
5. Troglitazone withdrawn from market
6. Validation of Analytical Procedures: Methodology
7. Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquid chromatography with ultraviolet (229 nm) detection
8. Simultaneous quantitation of pioglitazone and its metabolites in human serum by liquid chromatography and solid phase extraction